Aetna Revises Reimbursement Policy For Anemia Medications After CMS Decision

Aetna this month revised the reimbursement policy for several anemia medications — Aranesp and Epogen, marketed by Amgen, and Procrit, marketed by Johnson & Johnson — after [click link for full article]

More: continued here

Filed under: Blood on October 25th, 2007